iSpecimen Unveils Online Biospecimen Marketplace

Firm client iSpecimen has launched an online biospecimen marketplace for the life sciences industry. The company hopes that the marketplace will alleviate scientists' difficulty in finding high-quality samples of human material necessary to conduct research. The marketplace compiles available samples and allows users to search by patient information. Users can then order the corresponding materials. …

Continue reading iSpecimen Unveils Online Biospecimen Marketplace

MBBP’s Life Sciences Vector Newsletter, Spring 2017

Our Life Sciences team has published the Spring 2017 edition of its newsletter, Vector. Below you will find brief descriptions of the news and articles included in the publication. Read the full newsletter for more information. DAVID CZARNECKI AND STANLEY CHALVIRE ELEVATED WITHIN THE FIRM We are pleased to announce that David Czarnecki and Stanley Chalvire …

Continue reading MBBP’s Life Sciences Vector Newsletter, Spring 2017

Strategic Alliances: Pot of Gold or Pretty Poison? – Life Sciences Series Panel 4 Event, April 28

Our Life Sciences Series Panel 4 event, Strategic Alliances: Pot of Gold or Pretty Poison?, will be held on Friday, April 28 from 7:30-10am in our Waltham office. Moderated by corporate attorney John Hession, a panel of business development experts from Big Pharma and Small Biotech explore various research and collaboration structures, from options to license …

Continue reading Strategic Alliances: Pot of Gold or Pretty Poison? – Life Sciences Series Panel 4 Event, April 28

Early-Stage Life Science Financing: Event Recap

By: Erin Bryan On Thursday, March 30th, MBBP kicked off an Innovations in Life Sciences event at the Cambridge Innovation Center by hosting a panel entitled "Money and Molecules: Early-Stage Life Science Financing". The panel included Jeffrey Arnold, President & CEO of Arnold Strategies, LLC; Timothy Sullivan, Partner at Aju IB Investment; John Tagliamonte who serves …

Continue reading Early-Stage Life Science Financing: Event Recap

Early-Stage Life Science Financing Event – March 30

Don't miss our next event, Money and Molecules: Early-Stage Life Science Financing, on Thursday, March 30 from 3:30-5pm at the Cambridge Innovation Center. Moderated by corporate attorney John Hession, a panel of experts will discuss the current complex financing environment for early-stage life science companies. Among other topics, the panel discussion will include: Formulate a …

Continue reading Early-Stage Life Science Financing Event – March 30

MBBP client, Whitehead Institute, featured in New York Times article discussing Genomic research

The Whitehead Institute for Biomedical Research, a client of MBBP, is featured in a New York Times article about progressive research on topologically associating domains (TADs) in DNA. As the article explains, TADs are a newly discovered design feature of the genome that partition different groups of genes into neighborhoods. If these partitions are broken, various …

Continue reading MBBP client, Whitehead Institute, featured in New York Times article discussing Genomic research

MBBP’s Client Abpro Collaborating with MedImmune on Medical Advancement

MBBP's client Abpro, a pioneer in the field of industrial biochemistry, has recently entered into a Collaboration Agreement with MedImmune, the global biologics research and development arm of AstraZeneca. The collaboration will advance the development of a preclinical, novel bispecific antibody targeting angiopoietin-2 and vascular endothelial growth factor (Ang2-VEGF). Abpro will contribute its strong scientific, technical and clinical expertise …

Continue reading MBBP’s Client Abpro Collaborating with MedImmune on Medical Advancement

Panel 3 of Life Sciences Series To Be Held On September 22nd!

On Thursday, September 22nd, MBBP will host the third panel of our Life Sciences Series, "Funding Models in Biotech".  The panel will be held at the Cambridge Innovation Center (CIC) from 4:30pm - 6:00pm. The panel will discuss today's financing environment for emerging biotech companies, and the many complexities facing these companies in their attempts …

Continue reading Panel 3 of Life Sciences Series To Be Held On September 22nd!

Firm Client Applied BioMath Recognized in Greater Boston’s 2016 Small Business of the Year Awards

MBBP is thrilled to announce that client Applied BioMath, LLC is one of ten winners of the 2016 Small Business of the Year Awards (SBOY), announced by The Greater Boston Chamber of Commerce.  The SBOY recognizes smaller for-profit companies within the Greater Boston area who possess product innovation, workplace excellence, community and social responsibility, strong …

Continue reading Firm Client Applied BioMath Recognized in Greater Boston’s 2016 Small Business of the Year Awards

Highlights from MBBP Life Sciences Series Panel 2 – Laying the Foundation for Growth: Entity & Equity

On Wednesday June 22nd, the offices of Morse, Barnes-Brown & Pendleton were filled with a crowd of people for a life sciences panel discussion on “Laying the Foundation for Growth: Entity & Equity.”  Esteemed panelists included Marc Cote, COO of Accellient; Jeffrey Solomon, Managing Shareholder of Katz Nannis + Solomon; and MBBP’s own John Hession …

Continue reading Highlights from MBBP Life Sciences Series Panel 2 – Laying the Foundation for Growth: Entity & Equity